Literature DB >> 20360307

Evidence of extraordinary growth in the progressive enlargement of renal cysts.

Jared J Grantham1, Larry T Cook, Louis H Wetzel, Melissa A Cadnapaphornchai, Kyongtae T Bae.   

Abstract

BACKGROUND AND OBJECTIVES: In autosomal dominant polycystic kidney disease, cysts derived from tubules are detected at birth by ultrasound (threshold for detection >7.0 mm); thus, fetal cyst growth rates must exceed 2300%/yr. In adults, the combined renal cyst component enlarges at approximately 12%/yr by growth of individual cysts. To explore this discrepancy, the growth rates of individual cysts were determined in adult polycystic kidneys. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Diameter, volume, and growth rates of individual cysts were measured by magnetic resonance in 30 individual cysts in three adult patients over a span of 3 years. Results were confirmed in 22 cysts measured in five patients by computed tomography over a span of 11 years.
RESULTS: Mean cyst diameters were 20.4 +/- 9.9 mm (range 7.1 to 40.5 mm) at baseline and 25.8 +/- 15.6 mm (range 7.8 to 49.6 mm) after 3 years. Mean cyst volumes, determined by manual segmentation and summation of magnetic resonance cross sections, were 8.7 +/- 12.9 cm(3) (0.3 to 43.3 cm(3)) and 24.2 +/- 66.3 cm(3) (0.3 to 364.8 cm(3)) after 3 years. Mean cyst growth rates ranged from 6.9 to 23.9%/yr; the maximum growth rate was 71.1%/yr, far less than required to develop a 7-mm diameter cyst in utero. Results were similar in 22 cysts examined by computed tomography.
CONCLUSIONS: It was concluded that renal cysts detected by ultrasound in newborns must have grown at exuberant rates in utero; thereafter, expansion appears to proceed at much slower rates.

Entities:  

Mesh:

Year:  2010        PMID: 20360307      PMCID: PMC2863973          DOI: 10.2215/CJN.00550110

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  29 in total

1.  Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.

Authors:  W Lu; B Peissel; H Babakhanlou; A Pavlova; L Geng; X Fan; C Larson; G Brent; J Zhou
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Kyongtae T Bae; Sandro Rossetti; Vicente E Torres; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Philip J Kenney; Mark Consugar; Saulo Klahr; William M Bennett; Catherine M Meyers; Qin Jean Zhang; Paul A Thompson; Fang Zhu; J Philip Miller
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

3.  Volume progression in polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

4.  Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth.

Authors:  Olivia Boyer; Marie-France Gagnadoux; Geneviève Guest; Nathalie Biebuyck; Marina Charbit; Rémi Salomon; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2006-11-24       Impact factor: 3.714

5.  Renal asymmetry in children with autosomal dominant polycystic kidney disease.

Authors:  G Fick-Brosnahan; A M Johnson; J D Strain; P A Gabow
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

6.  A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.

Authors:  Klaus B Piontek; David L Huso; Alexander Grinberg; Lijuan Liu; Djahida Bedja; Haidan Zhao; Kathleen Gabrielson; Feng Qian; Changlin Mei; Heiner Westphal; Gregory G Germino
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

7.  A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.

Authors:  P G Starremans; X Li; P E Finnerty; L Guo; A Takakura; E G Neilson; J Zhou
Journal:  Kidney Int       Date:  2008-04-02       Impact factor: 10.612

8.  Characteristics of very early onset autosomal dominant polycystic kidney disease.

Authors:  G M Fick; A M Johnson; J D Strain; W J Kimberling; S Kumar; M L Manco-Johnson; I T Duley; P A Gabow
Journal:  J Am Soc Nephrol       Date:  1993-06       Impact factor: 10.121

9.  Determinants of renal volume in autosomal-dominant polycystic kidney disease.

Authors:  J J Grantham; L T Cook; V E Torres; J E Bost; A B Chapman; P C Harris; L M Guay-Woodford; K T Bae
Journal:  Kidney Int       Date:  2007-10-24       Impact factor: 10.612

10.  Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.

Authors:  Irma S Lantinga-van Leeuwen; Wouter N Leonhard; Annemieke van der Wal; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Hum Mol Genet       Date:  2007-10-11       Impact factor: 6.150

View more
  37 in total

1.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Malu Zandbergen; Kimberley Veraar; Susan van den Berg; Louise van der Weerd; Martijn Breuning; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2014-10-31       Impact factor: 10.121

Review 2.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 3.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

4.  The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

Authors:  Sravanthi Lavu; Lisa E Vaughan; Sarah R Senum; Timothy L Kline; Arlene B Chapman; Ronald D Perrone; Michal Mrug; William E Braun; Theodore I Steinman; Frederic F Rahbari-Oskoui; Godela M Brosnahan; Kyongtae T Bae; Douglas Landsittel; Fouad T Chebib; Alan Sl Yu; Vicente E Torres; Peter C Harris
Journal:  JCI Insight       Date:  2020-08-06

5.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Jared J Grantham; Larry T Cook; Vicente E Torres; Arlene B Chapman; Kyongtae Ty Bae; Michal Mrug; Peter C Harris; Frederic F Rahbari-Oskoui; Tiange Shi; William M Bennett
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

Review 6.  Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.

Authors:  Wouter N Leonhard; Hester Happe; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

Review 7.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

Review 8.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids.

Authors:  Shohei Kuraoka; Shunsuke Tanigawa; Atsuhiro Taguchi; Akitsu Hotta; Hitoshi Nakazato; Kenji Osafune; Akio Kobayashi; Ryuichi Nishinakamura
Journal:  J Am Soc Nephrol       Date:  2020-08-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.